Abstract:Molecular breast cancer subtypes were defined by gene expression prolife; however, immunohistochemical (IHC) expression can categorize breast cancers analogous to gene expression profiling. We aimed to evaluate distribution of these molecular breast cancer subtypes in our population and their association with clinocopathologic parameters. We retrospectively analyzed 1,104 cases of primary breast cancers over 3 years duration. ER, PR, Her2neu IHC staining, and subsequent fluorescent in situ hybridization studies (Her2neu gene amplification in cases with 2+ IHC staining) were performed to categorize breast cancer subtypes. Luminal A breast cancers were most frequent (45.8%) followed by triple negative (18.6%), luminal B (17.8%) and Her2neu (17.8%) subtypes. We found a strong association of breast cancer subtypes with tumor grade and Ki67 proliferation index with triple negative cancers being associated with higher grade and proliferation index. Significant association was seen with age groups, luminal A subtype occurring at a slightly older age, whereas triple negative and Her2neu cancers were more frequent in younger age group. We found a higher proportion of triple negative cancers in our set up, and they were found to have high-tumor grade and proliferation index along with presentation at younger age. As these cancers are associated with BRCA 1 mutations and abnormal BRCA 1 pathways, we suggest that large scale studies should be done to evaluate BRCA 1 mutations and abnormal BRCA 1 pathways in our population to establish risk factors for this highly aggressive tumor subtype.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the distribution of breast cancer molecular subtypes in South Asian populations and their associations with clinicopathological parameters. Specifically, the study aims to evaluate the distribution of different molecular subtypes of breast cancer (such as Luminal A, Luminal B, Her2neu, and triple - negative breast cancer) in South Asian populations and explore the relationships between these subtypes and clinicopathological parameters such as age, tumor size, grade, lymph node status, and Ki67 proliferation index. ### Research Background Breast cancer is a heterogeneous disease both biologically and phenotypically, comprising multiple different subtypes with different clinical and molecular characteristics and varying responses to adjuvant therapy. Common clinical and pathological factors include tumor size, grade, lymph node metastasis, lymphovascular invasion, hormone receptor status, HER2neu expression, and Ki67 index. Although the prognostic roles of most of these factors have been established, the prognostic value of the Ki67 index remains controversial due to lack of standardization. ### Research Objectives 1. **Evaluate the distribution of breast cancer molecular subtypes in South Asian populations**: Determine the distribution of Luminal A, Luminal B, Her2neu, and triple - negative breast cancer through immunohistochemistry (IHC) and fluorescence in - situ hybridization (FISH) techniques. 2. **Analyze the relationships between molecular subtypes and clinicopathological parameters**: Explore the associations between these subtypes and parameters such as age, tumor size, grade, lymph node status, and Ki67 proliferation index. ### Research Methods - **Sample selection**: A retrospective analysis was performed on 1,104 cases of primary breast cancer that were carried out at Liaquat National Hospital between 2010 and 2012. - **Detection methods**: IHC staining for ER, PR, and Her2neu was carried out, and FISH testing was performed on cases with Her2neu IHC 2+ to confirm gene amplification. - **Statistical analysis**: The Chi - square test was used to analyze the correlations between molecular subtypes and other clinicopathological parameters. ### Main Findings - **Molecular subtype distribution**: Luminal A was the most common subtype (45.8%), followed by triple - negative (18.6%), Luminal B (17.8%), and Her2neu (17.8%). - **Relationship between age and subtype**: The Luminal A subtype was more common in older patients, while the triple - negative and Her2neu subtypes were more common in younger patients. - **Tumor grade and Ki67 index**: The triple - negative subtype was significantly associated with higher tumor grade and Ki67 proliferation index. - **Lymph node status**: Although the association between lymph node - positive and molecular subtypes was not significant, the Luminal B subtype had a higher lymph node - positive rate. ### Conclusion The study found that the proportions of triple - negative and Her2neu subtypes were relatively high in South Asian populations, and these subtypes were associated with poorer prognoses. Given that triple - negative breast cancer is related to BRCA1 mutations and abnormal BRCA1 pathways, the study recommends large - scale studies to evaluate the risk factors for BRCA1 mutations and abnormal BRCA1 pathways in South Asian populations.

Molecular Subtypes of Breast Cancer in South Asian Population by Immunohistochemical Profile and Her2neu Gene Amplification by FISH Technique: Association with other Clinicopathologic Parameters

Abstract 5622: Integrative cross-platform characterisation of mammographic screen-detected breast cancer

Receptor subtype and outcome of breast cancer - Single-center experience from North India

Molecular Classification of Breast Carcinoma Based on the Prognostic Marker: A Clinico-pathological Correlation

Molecular Subtypes of Breast Cancer in a Tertiary Centre in Edo State: South-South Nigeria

Clinico-pathological co-relation using various immuno-histochemistry markers likeER, PR, HER-2 NEU, CK5/6, EGFR, KI-67 in carcinoma breast

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women

Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data

Metastatic Trends in Breast Cancer According to Molecular Subtypes, Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2neu Status

Clinical significance of four subtypes of breast cancer

Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI

Pathological features and prognosis of different molecular subtypes of breast cancer

Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression

[Relationship Between Breast Cancer Molecular Subtypes with Clinicopathological Characteristics and Prognosis].

Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review

Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

Molecular Profiling of a Triple-negative Breast Cancer Cohort in India for EGFR and AR expression analyzed for patient outcomes showed a distinct subset of cellular co-expression

Clinical Characteristics and Prognosis of Different Subtypes of Breast Cancer

Clinical implications of the intrinsic molecular subtypes of breast cancer

Association of Proliferative Activity in Invasive Ductal Carcinoma Breast in Pakistani Population

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors